UK markets closed
  • FTSE 100

    7,044.03
    -266.34 (-3.64%)
     
  • FTSE 250

    22,537.89
    -742.07 (-3.19%)
     
  • AIM

    1,181.62
    -22.34 (-1.86%)
     
  • GBP/EUR

    1.1776
    -0.0103 (-0.87%)
     
  • GBP/USD

    1.3338
    +0.0018 (+0.14%)
     
  • BTC-GBP

    40,825.89
    -3,180.21 (-7.23%)
     
  • CMC Crypto 200

    1,365.60
    -89.82 (-6.17%)
     
  • S&P 500

    4,594.62
    -106.84 (-2.27%)
     
  • DOW

    34,899.34
    -905.04 (-2.53%)
     
  • CRUDE OIL

    68.15
    -10.24 (-13.06%)
     
  • GOLD FUTURES

    1,785.50
    +1.20 (+0.07%)
     
  • NIKKEI 225

    28,751.62
    -747.66 (-2.53%)
     
  • HANG SENG

    24,080.52
    -659.64 (-2.67%)
     
  • DAX

    15,257.04
    -660.94 (-4.15%)
     
  • CAC 40

    6,739.73
    -336.14 (-4.75%)
     

Advanced Wound Care Management Market Report Up to 2031: Visiongain Research Inc

·6-min read

Visiongain has published a new report on Advanced Wound Care Management Market Report to 2031: Forecasts By Product Type (Dressings {Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Collagen Dressings, Hydrofiber Dressings, Wound Contact Layers, Superabsorbent Dressings, and Other Advanced Dressings}, Devices & Accessories {NPWT Devices & Accessories, Debridement Devices & Accessories, Wound Assessment & Monitoring Devices, and Other Devices & Accessories}, Grafts & Matrices, and Topical Agents), By Wound Type (Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Burns & Other Wounds), By End User (Hospitals, ASCs and Wound Care Centers, Homecare Settings, and Other End Users) PLUS COVID-19 Recovery Scenarios.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/advanced-wound-care-management-market/#download_sampe_div

COVID-19 Impact on Advanced Wound Care Management Market
The impact of the COVID-19 virus outbreak on certain medical products is estimated to be more prominent due to a decline in non-emergency medical care services and procedures. Over 2 million non-emergency procedures were canceled in the United Kingdom to free up healthcare resources to battle against this virus outbreak. Likewise, the hospitals witnessed a 30-60% drop in hospital visits after the declaration of the pandemic in the United States. As per the statistics published by Tissue Analytics, Inc., from March to April 2020, around a 40% decline has been seen in the hospital visits in wound centers compared to 2019.

Countries altogether have moved healthcare resources such as nurses, hospital beds, medical devices, and essential personnel for the management of patients with coronavirus. This has caused the exception of wound care from the crucial procedures list in most countries. Healthcare facilities with hospitals with dedicated wound care departments and specialized wound care clinics have been shut with the number of beds available in this situation as they are being used for COVID-19 patients. This has affected the patient visits to wound care centers, and casualty departments, mainly in the United States and European countries.

Market Drivers

Increasing Incidence of Chronic Wounds
The occurrence of chronic and surgical wounds has amplified considerably in the past decade, mainly owing to the increasing old population across the world and the growing incidence of diabetes and obesity-related diseases. Diabetes and obesity can cause the prevalence rate and difficulty to heal wounds such as ulcerations (leg or foot ulcers), infections, and surgical wounds, which need cures and sustain overpriced medical expenditures.

Worldwide, the growing incidence of chronic wounds including traumatic and surgical wounds is likely to upsurge the number of patients go through wound care treatment. According to the group purchasing organization – Prime Source, around 6.5 million people are with chronic wounds in the U.S. The total cost burden of wounds in the U.S. is $39 billion annually.

Similarly, as per the CDC, in the U.S., the total incidence of surgical wounds was nearly 2.8% in 2018. Thus, the rising incidence of hard-to-heal wounds upsurge the demand for these products for its treatment and consequently, pushing the global advanced wound care management market growth in the forecasted period.

Growing Awareness in Diabetic-Related Risks
People are looking for an imperative and effective cure for chronic wounds such as diabetic ulcers, vascular ulcers (e.g., venous and arterial ulcers), and pressure ulcers (PUs). Growing awareness is associated with the prevention of sepsis in people with diabetes. People are at high risk to develop sepsis and thus, it will create a lucrative opportunity for the global players to introduce new products into the market.

Get Detailed TOC @ https://www.visiongain.com/report/advanced-wound-care-management-market/#download_sampe_div

Market Opportunities

The Rising Potential of Developing Economies
Developing nations such as Brazil, China, India, and South Africa offer lucrative opportunities for the global key players operating in the target industry. The region such as the Asia Pacific and South America are still intact markets as compared to developed nations that have immense growth potential for these products. Due to this, most of the key players are focusing on these regions to tap into the emerging market.

Competitive Landscape
Key players operating in the global advanced wound care management market are Johnson and Johnson, Kinetic Concepts, Baxter International, Coloplast, 3M Company, Integra Life Sciences, Medtronic, Hematris Wound Care GmbH, Leap Therapeutics, and Smith & Nephew Plc.

The key players have adopted new product development, product launches, product approval, agreement, partnerships, and merger as its key business development strategies to tap into the global Advanced Wound Care Management market. For instance, on 3rd March 2020, Smith+Nephew introduced the PICO 14 Single-use NPWT device and bandages in the U.S. In addition to this, on 28th February 2020, the company announced its new high-technology manufacturing facility in Malaysia.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

To access the data contained in this document please email contactus@visiongain.com

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the advanced wound care management market and leading companies. You will find data, trends and predictions.

Find more Visiongain research reports on Pharma Medical Devices; click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.

Contact:

Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Web: https://www.visiongain.com
Follow Us: LinkedIn | Twitter

-

SOURCE Visiongain Limited.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting